LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 2.66 | 84.90 | 5 | 285 | 0.0175 | -0.8016 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 2.66 | 84.90 | 476 | 285 | 1.6659 | 1.6768 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 2.66 | 84.90 | 626 | 285 | 2.1908 | 2.1301 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 4.36 | 84.90 | 10 | 322 | 0.0310 | -0.6706 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 4.36 | 84.90 | 595 | 322 | 1.8446 | 1.7485 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 4.36 | 84.90 | 3 | 322 | 0.0093 | -0.8237 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 4.36 | 84.90 | 688 | 322 | 2.1329 | 1.9638 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 6.06 | 84.90 | 15 | 365 | 0.0410 | -0.5609 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 6.06 | 84.90 | 669 | 365 | 1.8306 | 1.6652 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 6.06 | 84.90 | 5 | 365 | 0.0137 | -0.7394 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 6.06 | 84.90 | 767 | 365 | 2.0988 | 1.8439 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.77 | 84.90 | 18 | 411 | 0.0438 | -0.4941 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.77 | 84.90 | 759 | 411 | 1.8456 | 1.6179 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.77 | 84.90 | 3 | 411 | 0.0073 | -0.7698 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.77 | 84.90 | 832 | 411 | 2.0232 | 1.7257 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 9.47 | 84.90 | 13 | 447 | 0.0291 | -0.5428 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 9.47 | 84.90 | 820 | 447 | 1.8327 | 1.5748 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 9.47 | 84.90 | 5 | 447 | 0.0112 | -0.6930 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 9.47 | 84.90 | 903 | 447 | 2.0182 | 1.6805 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 11.18 | 84.90 | 18 | 492 | 0.0366 | -0.4575 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 11.18 | 84.90 | 869 | 492 | 1.7650 | 1.5022 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 11.18 | 84.90 | 8 | 492 | 0.0162 | -0.6060 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 11.18 | 84.90 | 965 | 492 | 1.9600 | 1.6078 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.88 | 84.90 | 21 | 531 | 0.0395 | -0.4103 | MN20160318_Q02 | E22 |